{
  "ticker": "KYTX",
  "success": true,
  "price": {
    "current": 8.21,
    "currency": "USD",
    "day_high": 8.446,
    "day_low": 8.03,
    "52_week_high": 13.67,
    "52_week_low": 1.78
  },
  "market_cap": {
    "value": 489370208.0,
    "currency": "USD"
  },
  "shares_outstanding": 59606603.0,
  "volume": {
    "last": 673932,
    "average_30d": 945923
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -2.4097517,
    "price_to_book": 2.3659942
  },
  "company_info": {
    "name": "Kyverna Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 187156000.0,
    "total_liabilities": 35210000.0,
    "stockholders_equity": 151946000.0,
    "cash": 34164000.0,
    "marketable_securities": 136974000.0,
    "total_liquidity": 171138000.0,
    "total_debt": 5024000.0,
    "long_term_debt": 1339000.0,
    "current_debt": 3685000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -43321000.0,
    "free_cash_flow": -43713000.0,
    "investing_cash_flow": 22557000.0,
    "financing_cash_flow": 1488000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 38727000.0,
    "research_and_development": 30457000.0,
    "interest_expense": 7000.0,
    "net_income": -36787000.0,
    "revenue": 0.0,
    "gross_profit": null,
    "ebitda": -36365000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:48:49.577659",
    "url": "https://finance.yahoo.com/quote/KYTX",
    "data_hash": "2c7bdf6464bef9ee"
  }
}